Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Triplet therapy with androgen deprivation, docetaxel, and androgen receptor signalling inhibitors in metastatic castration-sensitive prostate cancer: A meta-analysisEur. J. Cancer 2022 Aug 11;173(2022)276-284, C Ciccarese, R Iacovelli, CN Sternberg, S Gillessen, G Tortora, K Fizazi
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.